rosiglitazone has been researched along with Cochlear Hearing Loss in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Liu, J; Shi, H; Sun, Y; Xia, L; Yang, G; Yin, S | 1 |
1 other study(ies) available for rosiglitazone and Cochlear Hearing Loss
| Article | Year |
|---|---|
Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression.
Topics: Animals; Dexamethasone; Dual Specificity Phosphatase 1; Evoked Potentials, Auditory, Brain Stem; Glucocorticoids; Guinea Pigs; Hearing; Hearing Loss, Sensorineural; Lipopolysaccharides; Male; Rosiglitazone | 2019 |